(19)
(11) EP 1 231 938 A2

(12)

(88) Date of publication A3:
14.02.2002

(43) Date of publication:
21.08.2002 Bulletin 2002/34

(21) Application number: 00978535.3

(22) Date of filing: 09.11.2000
(51) International Patent Classification (IPC)7A61K 45/06, A61P 35/00
(86) International application number:
PCT/US0031/039
(87) International publication number:
WO 0103/4137 (17.05.2001 Gazette 2001/20)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.11.1999 US 164786 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • FLEISCH, Jerome, Herbert
    Carmel, IN 46032 (US)
  • BENJAMIN, Roger, Stuart
    Carmel, IN 46033 (US)
  • SAWYER, Jason, Scott
    Indianapolis, IN 46220 (US)
  • TEICHER, Beverly, Ann
    Carmel, IN 46033 (US)
  • BEIGHT, Douglas, Wade
    Frankfort, IN 46041 (US)
  • SMITH, Edward, C., R.
    Fishers, IN 46038 (US)
  • MCMILLEN, William, Thomas
    Fishers, IN 46038 (US)

(74) Representative: Burnside, Ivan John et al
Eli Lilly and Company LimitedLilly Research CentreErl Wood Manor
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER